课题基金 / 基金详情

Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer

Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer
泮托拉唑和多西他赛治疗转移性去势抵抗性前列腺癌的 II 期临床试验
批准号:
238166
负责人:
Tannock Ian F
金额:
$21.65万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2014-09-01

项目摘要

项目成果

Tannock Ian F的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Men with metastatic prostate cancer commonly have tumours that have spread to lymph nodes and to their bones, and they frequently experience symptoms of tiredness and pain. Initial treatment is hormonal, with drugs that decrease the level and/or activity
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Distribution of anticancer drugs and target cells within solid tumours
  • 批准号:
    189603
  • 项目类别:
    Operating Grants
  • 资助金额:
    $27.68万
  • 财政年份:
    2009
  • 负责人:
    Tannock Ian F
  • 依托单位:
海外基金